Insider · CIK 0001799780
Jill M. Quigley
Files at TERN (Terns Pharmaceuticals, Inc.). First filing Nov 5, 2025, latest Nov 5, 2025.
Jill M. Quigley files SEC Form 4 as director at TERN (Terns Pharmaceuticals, Inc.). Since Nov 5, 2025, Jill M. Quigley has reported 0 open-market buys worth $0 and 1 open-market sell worth $441k, the latest filed on Nov 5, 2025.
A track record needs three past buys with six months of prices behind them; Jill M. Quigley has 0, so none is measured yet.
The newest scored trade: sold $441k of TERN on Nov 4, 2025, filed Nov 5, 2025, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $441k.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Terns Pharmaceuticals, Inc. | $441k 24,520 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 4, 2025 | TERN TERNS PHARMACEUTICALS INC | 24,520 0.03% of outstanding | $344k | Nov 4, 2025 | none |
| Jan 6, 2025 | TERN Terns Pharmaceuticals, Inc. | 8,760 0.01% of outstanding | $50k | Jan 6, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,697 | $0.00 | $0 | 1,697 | Feb 2, 2026 |
| Nov 4, 2025 | TERN Terns Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +24,520 | $9.24 | $227k | 24,520 | Nov 5, 2025 |
| Nov 4, 2025 | TERN Terns Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -24,520 | $18.00 | $441k | 0 | Nov 5, 2025 |
| Nov 4, 2025 | TERN Terns Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -24,520 | $0.00 | $0 | 3,955 | Nov 5, 2025 |
| Jun 11, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 12, 2025 |
Questions about Jill M. Quigley
Answered from the filings on this page, as of the latest one.
Is Jill M. Quigley buying or selling?
In the last 12 months Jill M. Quigley reported 0 open-market buys worth $0 and 1 open-market sell worth $441k on SEC Form 4; the latest was sold $441k of TERN on Nov 4, 2025. Grants, option exercises and tax withholding are not counted.
How did Jill M. Quigley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jill M. Quigley has 0.
Where does Jill M. Quigley file Form 4?
Jill M. Quigley has filed Form 4 at TERN (Terns Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.